Macrolide and fluoroquinolone (levofloxacin) resistances among Streptococcus pneumoniae strains: significant trends from the SENTRY Antimicrobial Surveillance Program (North America, 1997-1999).
作者信息
Jones R N, Pfaller M A
出版信息
J Clin Microbiol. 2000 Nov;38(11):4298-9. doi: 10.1128/JCM.38.11.4298-4299.2000.
Abstract
摘要
相似文献
1
Macrolide and fluoroquinolone (levofloxacin) resistances among Streptococcus pneumoniae strains: significant trends from the SENTRY Antimicrobial Surveillance Program (North America, 1997-1999).肺炎链球菌菌株中对大环内酯类和氟喹诺酮类（左氧氟沙星）的耐药性：来自哨兵抗菌监测计划（北美，1997 - 1999年）的显著趋势。
J Clin Microbiol. 2000 Nov;38(11):4298-9. doi: 10.1128/JCM.38.11.4298-4299.2000.
2
Activity of oral agents against pediatric isolates of Streptococcus pneumoniae.口服制剂对肺炎链球菌儿科分离株的活性。
Diagn Microbiol Infect Dis. 2001 Mar;39(3):195-7. doi: 10.1016/s0732-8893(01)00209-7.
3
Trends in ciprofloxacin nonsusceptibility and levofloxacin resistance among Streptococcus pneumoniae isolates in North America.北美肺炎链球菌分离株中对环丙沙星不敏感及对左氧氟沙星耐药的趋势。
J Clin Microbiol. 2001 Jul;39(7):2748-50. doi: 10.1128/JCM.39.7.2748-2750.2001.
4
Emergence of multidrug-resistant Streptococcus pneumoniae: report from the SENTRY Antimicrobial Surveillance Program (1999-2003).多重耐药肺炎链球菌的出现：哨兵抗菌监测项目（1999 - 2003年）报告
Diagn Microbiol Infect Dis. 2006 Sep;56(1):69-74. doi: 10.1016/j.diagmicrobio.2005.12.008. Epub 2006 Mar 20.
5
Therapeutic options among broad-spectrum beta-lactams for infections caused by levofloxacin-nonsusceptible Streptococcus pneumoniae.针对左氧氟沙星不敏感的肺炎链球菌所致感染，在广谱β-内酰胺类药物中的治疗选择。
Diagn Microbiol Infect Dis. 2005 Jun;52(2):129-33. doi: 10.1016/j.diagmicrobio.2004.12.009.
6
Genetic relatedness of levofloxacin-nonsusceptible Streptococcus pneumoniae isolates from North America.来自北美的左氧氟沙星不敏感肺炎链球菌分离株的遗传相关性。
J Clin Microbiol. 2003 Jun;41(6):2458-64. doi: 10.1128/JCM.41.6.2458-2464.2003.
7
Antimicrobial resistance of Streptococcus pneumoniae isolates in 1999 and 2000 in Madrid, Spain: a multicentre surveillance study.
J Antimicrob Chemother. 2001 Feb;47(2):215-8. doi: 10.1093/jac/47.2.215.
8
Comparative antimicrobial activity of trovafloxacin tested against 3049 Streptococcus pneumoniae isolates from the 1997-1998 respiratory infection season.曲伐沙星对1997 - 1998年呼吸道感染季节分离出的3049株肺炎链球菌的抗菌活性比较
Diagn Microbiol Infect Dis. 1998 Oct;32(2):119-26. doi: 10.1016/s0732-8893(98)00072-8.
9
The susceptibility of Streptococcus pneumoniae to levofloxacin and other antibiotics.肺炎链球菌对左氧氟沙星及其他抗生素的敏感性。
J Antimicrob Chemother. 1999 Jun;43 Suppl C:1-3. doi: 10.1093/jac/43.suppl_3.1.
10
Prevalence and molecular analysis of macrolide and fluoroquinolone resistance among isolates of Streptococcus pneumoniae collected during the 2000-2001 PROTEKT US Study.2000 - 2001年美国PROTEKT研究期间收集的肺炎链球菌分离株中大环内酯类和氟喹诺酮类耐药性的流行情况及分子分析
J Clin Microbiol. 2004 Nov;42(11):4980-7. doi: 10.1128/JCM.42.11.4980-4987.2004.
引用本文的文献
1
Global fluoroquinolone resistance epidemiology and implictions for clinical use.全球氟喹诺酮类药物耐药性流行病学及其临床应用意义
Interdiscip Perspect Infect Dis. 2012;2012:976273. doi: 10.1155/2012/976273. Epub 2012 Oct 14.
2
Guide to selection of fluoroquinolones in patients with lower respiratory tract infections.下呼吸道感染患者氟喹诺酮类药物的选择指南。
Drugs. 2005;65(7):949-91. doi: 10.2165/00003495-200565070-00004.
3
Antimicrobial drug prescribing for pneumonia in ambulatory care.
Emerg Infect Dis. 2005 Mar;11(3):380-4. doi: 10.3201/eid1103.040819.
4
Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes.肺炎链球菌和化脓性链球菌中的抗生素选择压力与耐药性
Emerg Infect Dis. 2004 Mar;10(3):514-7. doi: 10.3201/eid1003.030252.
5
New developments in antibacterial choice for lower respiratory tract infections in elderly patients.老年患者下呼吸道感染抗菌药物选择的新进展
Drugs Aging. 2004;21(3):167-86. doi: 10.2165/00002512-200421030-00003.
6
Telithromycin- and fluoroquinolone-resistant Streptococcus pneumoniae in Taiwan with high prevalence of resistance to macrolides and beta-lactams: SMART program 2001 data.台湾地区对泰利霉素和氟喹诺酮耐药的肺炎链球菌，对大环内酯类和β-内酰胺类耐药率高：2001年SMART项目数据
Antimicrob Agents Chemother. 2003 Jul;47(7):2145-51. doi: 10.1128/AAC.47.7.2145-2151.2003.
7
Genetic relatedness of levofloxacin-nonsusceptible Streptococcus pneumoniae isolates from North America.来自北美的左氧氟沙星不敏感肺炎链球菌分离株的遗传相关性。
J Clin Microbiol. 2003 Jun;41(6):2458-64. doi: 10.1128/JCM.41.6.2458-2464.2003.
8
Worldwide antimicrobial susceptibility patterns and pharmacodynamic comparisons of gatifloxacin and levofloxacin against Streptococcus pneumoniae: report from the Antimicrobial Resistance Rate Epidemiology Study Team.加替沙星和左氧氟沙星对肺炎链球菌的全球抗菌药物敏感性模式及药效学比较：抗菌药物耐药率流行病学研究团队报告
Antimicrob Agents Chemother. 2003 Jan;47(1):292-6. doi: 10.1128/AAC.47.1.292-296.2003.
9
In vitro activities of tigecycline (GAR-936) against recently isolated clinical bacteria in Spain.替加环素（GAR-936）对西班牙近期分离的临床细菌的体外活性。
Antimicrob Agents Chemother. 2002 Mar;46(3):892-5. doi: 10.1128/AAC.46.3.892-895.2002.
10
Trends in ciprofloxacin nonsusceptibility and levofloxacin resistance among Streptococcus pneumoniae isolates in North America.北美肺炎链球菌分离株中对环丙沙星不敏感及对左氧氟沙星耐药的趋势。
J Clin Microbiol. 2001 Jul;39(7):2748-50. doi: 10.1128/JCM.39.7.2748-2750.2001.
本文引用的文献
1
Will pneumococci put quinolones in their place?肺炎球菌会被喹诺酮类药物制服吗？
J Antimicrob Chemother. 1999 Oct;44(4):425-7. doi: 10.1093/jac/44.4.425.
2
Survey of susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis isolates to 26 antimicrobial agents: a prospective U.S. study.肺炎链球菌、流感嗜血杆菌和卡他莫拉菌分离株对26种抗菌药物的敏感性调查：一项美国前瞻性研究。
Antimicrob Agents Chemother. 1999 Nov;43(11):2612-23. doi: 10.1128/AAC.43.11.2612.
3
Prevalence of antimicrobial resistance in respiratory tract isolates of Streptococcus pneumoniae: results of a Canadian national surveillance study. The Canadian Respiratory Infection Study Group.肺炎链球菌呼吸道分离株的抗菌药物耐药性患病率：一项加拿大全国性监测研究的结果。加拿大呼吸道感染研究组
Antimicrob Agents Chemother. 1999 Oct;43(10):2504-9. doi: 10.1128/AAC.43.10.2504.
4
Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network.加拿大肺炎链球菌对氟喹诺酮类药物的敏感性降低。加拿大细菌监测网络。
N Engl J Med. 1999 Jul 22;341(4):233-9. doi: 10.1056/NEJM199907223410403.
5
Comparative antimicrobial activity of trovafloxacin tested against 3049 Streptococcus pneumoniae isolates from the 1997-1998 respiratory infection season.曲伐沙星对1997 - 1998年呼吸道感染季节分离出的3049株肺炎链球菌的抗菌活性比较
Diagn Microbiol Infect Dis. 1998 Oct;32(2):119-26. doi: 10.1016/s0732-8893(98)00072-8.
Zotero 插件